Augmented experimental design for bioavailability enhancement: a robust formulation of abiraterone acetate

References

• Abouelmagd, S.A., et al., 2015. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Molecular pharmaceutics, 12 (3), 997–1003.
   PubMed Web of Science ®Google Scholar
• Akhtartavan, S., et al., 2019. Evaluation of a self-nanoemulsifying docetaxel delivery system. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 109, 2427–2433.
   PubMed Web of Science ®Google Scholar
• Alshahrani, S.M., et al., 2018. Anticancer efficacy of self-nanoemulsifying drug delivery system of sunitinib malate. Aaps pharmscitech, 19 (1), 123–133.
   PubMed Web of Science ®Google Scholar
• Attard, G., et al., 2008. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. Journal of clinical oncology: official journal of the American society of clinical oncology, 26 (28), 4563–4571.
   PubMed Web of Science ®Google Scholar
• Bezerra-Souza, A., et al., 2019. Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis. Pharmaceutics, 11 (7), 353.
   PubMedGoogle Scholar
• Cho, H. Y., et al., 2016. Preparation and evaluation of solid-self-emulsifying drug delivery system containing paclitaxel for lymphatic delivery. Journal of nanomaterials, 2016, 1–14.
   Web of Science ®Google Scholar
• Chouhan, P. and Saini, T., 2016. D-optimal design and development of microemulsion based transungual drug delivery formulation of ciclopirox olamine for treatment of onychomycosis. Indian journal of pharmaceutical sciences, 78 (4), 498–511.
   Google Scholar
• Coughlin, J.E., et al., 2012. Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioate. Drug metabolism and disposition, 40 (5), 970–981.
   PubMedGoogle Scholar
• Craig, D., et al., 1995. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. International journal of pharmaceutics, 114 (1), 103–110.
   Web of Science ®Google Scholar
• Date, A.A., et al., 2010. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (London, England), 5 (10), 1595–1616.
   PubMed Web of Science ®Google Scholar
• FDA. 2009. Guidance for industry. Q8 (R2) pharmaceutical development. Silver Spring, MD: Department of Human and Human Services.
   Google Scholar
• Geboers, S., et al., 2016. The effect of food on the intraluminal behavior of abiraterone acetate in man. Journal of pharmaceutical sciences, 105 (9), 2974–2981.
   PubMedGoogle Scholar
• Grenier, P. and Vergnault, G., 2015. Pharmaceutical composition comprising abiraterone acetate. Google Patents.
   Google Scholar
• Gupta, A., et al., 2016. Nanoemulsions: formation, properties and applications. Soft matter, 12 (11), 2826–2841.
   PubMed Web of Science ®Google Scholar
• Gupta, S., et al., 2021. Coelogin ameliorates metabolic dyshomeostasis by regulating adipogenesis and enhancing energy expenditure in adipose tissue. Pharmacological research, 172, 105776.
   PubMedGoogle Scholar
• Gurav, S., et al., 2012. Development and validation of a highly sensitive method for the determination of abiraterone in rat and human plasma by LC-MS/MS-ESI: application to a pharmacokinetic study. Biomedical chromatography: BMC, 26 (6), 761–768.
   PubMedGoogle Scholar
• Hamed, R., et al., 2016. pH-dependent solubility and dissolution behavior of Carvedilol-Case Example of a Weakly Basic BCS Class II Drug. AAPS PharmSciTech, 17 (2), 418–426.
   PubMed Web of Science ®Google Scholar
• Imada, C., et al., 2015. Improvement of oral bioavailability of N-251, a novel antimalarial drug, by increasing lymphatic transport with long-chain fatty acid-based self-nanoemulsifying drug delivery system. Pharmaceutical research, 32 (8), 2595–2608.
   PubMed Web of Science ®Google Scholar
• Jain, A.K., Thanki, K., and Jain, S., 2014. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharmaceutical research, 31 (4), 923–945.
   PubMed Web of Science ®Google Scholar
• Jain, S., et al., 2015. Cyclosporine A loaded self-nanoemulsifying drug delivery system (SNEDDS): implication of a functional excipient based co-encapsulation strategy on oral bioavailability and nephrotoxicity. RSC advances, 5 (61), 49633–49642.
   Web of Science ®Google Scholar
• Jaiswal, P., et al., 2014. Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. International journal of pharmaceutical investigation, 4 (4), 195.
   PubMedGoogle Scholar
• Kumar, N. and Mandal, A., 2018. Surfactant stabilized oil-in-water nanoemulsion: stability, interfacial tension, and rheology study for enhanced oil recovery application. Energy & fuels, 32 (6), 6452–6466.
   Web of Science ®Google Scholar
• Liu, C., et al., 2018. Self-nanoemulsifying drug delivery system of tetrandrine for improved bioavailability: physicochemical characterization and pharmacokinetic study. BioMed research international, 2018, 6763057.
   PubMed Web of Science ®Google Scholar
• Liu, X. L., et al., 1999. Glutathione antagonized cyclophosphamide-and acrolein-induced cytotoxicity of PC3 cells and immunosuppressive actions in mice. Zhongguo yao li xue bao = Acta pharmacologica sinica, 20, 643–646.
   PubMedGoogle Scholar
• Ochoa De Olza, M., et al., 2014. Abiraterone after docetaxel in metastatic castration-resistant prostate cancer (mCRPC) patients (p) in an off-protocol routine clinical setting. American society of clinical oncology, 32, e16087.
   Google Scholar
• Panda, B.P., et al., 2019. Fabrication of second generation smarter PLGA based nanocrystal carriers for improvement of drug delivery and therapeutic efficacy of gliclazide in type-2 diabetes rat model. Scientific reports, 9 (1), 1–15.
   PubMedGoogle Scholar
• Park, H., Ha, E. S., and Kim, M. S., 2020. Current status of supersaturable self-emulsifying drug delivery systems. Pharmaceutics, 12 (4), 365.
   PubMed Web of Science ®Google Scholar
• Patel, J., et al., 2011. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. Journal of advanced pharmaceutical technology & research, 2 (1), 9–16.
   PubMedGoogle Scholar
• Pouton, C.W., 2000. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. European journal of pharmaceutical sciences, 11, S93–S98.
   PubMed Web of Science ®Google Scholar
• Rai, Y., et al., 2018. Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Scientific reports, 8 (1), 1531–1531.
   PubMedGoogle Scholar
• Ryan, C.J. and Cheng, M.L., 2013. Abiraterone acetate for the treatment of prostate cancer. Expert opinion on pharmacotherapy, 14 (1), 91–96.
   PubMed Web of Science ®Google Scholar
• Schultz, H.B., et al., 2020a. Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate. International journal of pharmaceutics, 577, 119069.
   PubMedGoogle Scholar
• Schultz, H.B., et al., 2020b. Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids. International journal of pharmaceutics, 582, 119264.
   PubMedGoogle Scholar
• Shakeel, F., Iqbal, M., and Ezzeldin, E., 2016. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system. The journal of pharmacy and pharmacology, 68 (6), 772–780.
   PubMed Web of Science ®Google Scholar
• Sharma, G., et al., 2015. Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance. RSC advances, 5 (87), 71500–71513.
   Google Scholar
• Sharma, M., et al., 2016. Design of folic acid conjugated chitosan nano-cur–bioenhancers to attenuate the hormone-refractory metastatic prostate carcinoma by augmenting oral bioavailability. RSC advances, 6 (30), 25137–25148.
   Web of Science ®Google Scholar
• Shen, J. and Burgess, D.J., 2013. In Vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug delivery and translational research, 3 (5), 409–415.
   PubMed Web of Science ®Google Scholar
• Singh, D., 2016. Defining desirable natural product derived anticancer drug space: optimization of molecular physicochemical properties and ADMET attributes. ADMET and DMPK, 4 (2), 98–113.
   Google Scholar
• Singh, G. and Pai, R.S., 2015. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug delivery, 22 (4), 522–530.
   PubMed Web of Science ®Google Scholar
• Solymosi, T., et al., 2017. Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements. International journal of pharmaceutics, 532 (1), 427–434.
   PubMedGoogle Scholar
• Stein, M.N., Goodin, S., and Dipaola, R.S., 2012. Abiraterone in prostate cancer: a new angle to an old problem. Clinical cancer research: an official journal of the American association for cancer research, 18 (7), 1848–1854.
   PubMedGoogle Scholar
• Valicherla, G.R., et al., 2016. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Scientific reports, 6, 26895.
   PubMed Web of Science ®Google Scholar
• Verma, S., et al., 2009. Quality by design approach to understand the process of nanosuspension preparation. International journal of pharmaceutics, 377 (1–2), 185–198.
   PubMed Web of Science ®Google Scholar
• Vijayakumar, M.R., et al., 2016. Intravenous administration of trans-resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines. RSC advances, 6 (55), 50336–50348.
   Web of Science ®Google Scholar
• Wang, T., et al., 2018. Solid lipid-polymer hybrid nanoparticles by in situ conjugation for oral delivery of astaxanthin. Journal of agricultural and food chemistry, 66 (36), 9473–9480.
   PubMed Web of Science ®Google Scholar
• Weissman, S.A. and Anderson, N.G., 2015. Design of experiments (DoE) and process optimization. A review of recent publications. Organic process research & development, 19 (11), 1605–1633.
   Web of Science ®Google Scholar
• Wu, L., et al., 2015. A self-microemulsifying drug delivery system (SMEDDS) for a novel medicative compound against depression: a preparation and bioavailability study in rats. AAPS PharmSciTech, 16 (5), 1051–1058.
   PubMedGoogle Scholar
• Xue, M., et al., 2013. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. International journal of nanomedicine, 8, 4677.
   PubMed Web of Science ®Google Scholar
• Zeng, L., Xin, X., and Zhang, Y., 2017. Development and characterization of promising Cremophor EL-stabilized o/w nanoemulsions containing short-chain alcohols as a cosurfactant. RSC advances, 7 (32), 19815–19827.
   Web of Science ®Google Scholar
• Zhang, J., et al., 2015. Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system. Molecular pharmaceutics, 12 (2), 504–513.
   PubMed Web of Science ®Google Scholar